Kiora Pharmaceuticals Inc (KPRX) — Cash Flow Reinvestment Rate
Kiora Pharmaceuticals Inc (KPRX) has a Cash Flow Reinvestment Rate of 2.09x as of September 2024, reinvesting $1.92 Million (capex $3.00 plus investments $-1.92 Million) from operating cash flow of $920.06K. Check KPRX cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Kiora Pharmaceuticals Inc Cash Flow Reinvestment Rate (2024–2024)
Historical reinvestment intensity for Kiora Pharmaceuticals Inc across 1 annual periods. Explore KPRX operating cash to total liabilities to assess how comfortably operating cash covers total debt obligations.
Annual Cash Flow Reinvestment Rate for Kiora Pharmaceuticals Inc (2024–2024)
Year-by-year capital reinvestment analysis for Kiora Pharmaceuticals Inc. For live market cap and broader valuation context, see KPRX market cap.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 2.65x | $22.67 Million | $8.56 Million | $6.26K | — |